Citadel Advisors’s Elanco Animal Health ELAN Stock Holding History

Citadel Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.75M	Sell	114,900 -25,000	-18%	-$611K	﹤0.01%	5440
2025 Q4	$3.17M	Sell	139,900 -23,600	-14%	-$514K	﹤0.01%	5068
2025 Q3	$3.29M	Buy	163,500 +44,300	+37%	+$742K	﹤0.01%	5137
2025 Q2	$1.7M	Buy	119,200 +26,300	+28%	+$307K	﹤0.01%	6026
2025 Q1	$975K	Sell	92,900 -61,700	-40%	-$698K	﹤0.01%	7015
2024 Q4	$1.87M	Sell	154,600 -4,900	-3%	-$64.1K	﹤0.01%	5766
2024 Q3	$2.34M	Sell	159,500 -46,800	-23%	-$652K	﹤0.01%	5233
2024 Q2	$2.98M	Buy	206,300 +20,200	+11%	+$323K	﹤0.01%	4578
2024 Q1	$3.03M	Buy	186,100 +10,800	+6%	+$169K	﹤0.01%	4770
2023 Q4	$2.61M	Sell	175,300 -22,600	-11%	-$256K	﹤0.01%	4895
2023 Q3	$2.22M	Buy	197,900 +41,800	+27%	+$485K	﹤0.01%	5036
2023 Q2	$1.57M	Sell	156,100 -89,800	-37%	-$833K	﹤0.01%	5602
2023 Q1	$2.31M	Sell	245,900 -22,400	-8%	-$264K	﹤0.01%	5085
2022 Q4	$3.28M	Sell	268,300 -51,600	-16%	-$643K	﹤0.01%	4600
2022 Q3	$3.97M	Buy	319,900 +201,100	+169%	+$3.52M	﹤0.01%	4263
2022 Q2	$2.33M	Sell	118,800 -29,100	-20%	-$689K	﹤0.01%	5248
2022 Q1	$3.86M	Sell	147,900 -68,800	-32%	-$1.83M	﹤0.01%	4681
2021 Q4	$6.15M	Sell	216,700 -152,000	-41%	-$4.73M	﹤0.01%	3927
2021 Q3	$11.8M	Buy	368,700 +189,400	+106%	+$6.36M	﹤0.01%	2787
2021 Q2	$6.22M	Buy	179,300 +1,600	+0.9%	+$52.8K	﹤0.01%	3980
2021 Q1	$5.23M	Sell	177,700 -16,700	-9%	-$514K	﹤0.01%	4154
2020 Q4	$5.96M	Buy	194,400 +1,600	+0.8%	+$48.8K	﹤0.01%	3389
2020 Q3	$5.38M	Buy	192,800 +87,700	+83%	+$2.22M	﹤0.01%	3041
2020 Q2	$2.25M	Sell	105,100 -3,000	-3%	-$66.3K	﹤0.01%	4350
2020 Q1	$2.42M	Buy	108,100 +76,000	+237%	+$2.08M	﹤0.01%	3839
2019 Q4	$945K	Sell	32,100 -98,600	-75%	-$2.68M	﹤0.01%	5687
2019 Q3	$3.48M	Buy	130,700 +34,600	+36%	+$1.04M	﹤0.01%	3620
2019 Q2	$3.25M	Sell	96,100 -58,100	-38%	-$1.89M	﹤0.01%	3732
2019 Q1	$4.95M	Buy	+154,200	New	+$4.74M	﹤0.01%	3015

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Citadel Advisors's ELAN Position: Q1 2026 in Review

Citadel Advisors increased its Elanco Animal Health (ELAN) stake by 19% in Q1 2026, buying an estimated $16.8M and bringing the position to 4,387,127 shares worth $105M. The position accounts for 0.02% of the portfolio, ranked #774.

Citadel Advisors first reported a position in ELAN in Q3 2018 and has held it in 30 quarters since. The position peaked at $251M in Q1 2019. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Citadel Advisors held 4,387,127 shares of Elanco Animal Health worth $105M as of Q1 2026.
Citadel Advisors bought 689,001 Elanco Animal Health shares in Q1 2026, an estimated $16.8M.
Elanco Animal Health made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #774 holding.
Citadel Advisors first reported a position in Elanco Animal Health in Q3 2018 and has held it in 30 quarters since.
Citadel Advisors's Elanco Animal Health position peaked at $251M in Q1 2019.
516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.